Lighthouse Pharmaceuticals, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study of LHP588 in Subjects with P. Gingivalis-Positive Alzheimer's Disease
Phase 2
Recruiting
- Conditions
- Alzheimer DiseaseAlzheimer Disease Due to P. Gingivalis
- Interventions
- Drug: Placebo Drug
- First Posted Date
- 2025-02-26
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Lighthouse Pharmaceuticals, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT06847321
- Locations
- 🇺🇸
Northwest Clinical Research Center, Bellevue, Washington, United States
News
No news found